Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
4 papers
Recent·Most cited
C. Cintas, T. Douche, Z. Dantes…·J. Guillermet-Guibert
This study identifies adaptive phosphoprotein responses to isoform-selective PI3K inhibitors in pancreatic cancer, showing that combination therapy can overcome resistance.
J. Doffo, S. A. Bamopoulos, H. Kose…·M. Wirth
The paper identifies RUNX1 inhibition as a strategy to induce NOXA-dependent apoptosis in pancreatic cancer, showing it blocks tumor growth in vivo and in organoids.
L. Thurner, N. Fadle, M. Bewarder…·S. Koerper
This study identifies autoantibodies against PGRN and IL-1-Ra in critical COVID-19 patients, linked to hyperphosphorylated isoforms and increased inflammation.
K. Lankes, Z. Hassan, M. J. Doffo…·M. Wirth
The paper identifies bortezomib as a potential therapy for MYC hyperactive pancreatic cancer by showing its sensitivity to proteasome inhibition.